...
首页> 外文期刊>Eurosurveillance >Mycoplasma pneumoniae: now in the focus of clinicians and epidemiologists
【24h】

Mycoplasma pneumoniae: now in the focus of clinicians and epidemiologists

机译:肺炎支原体:现在是临床医生和流行病学家关注的焦点

获取原文

摘要

Some 50 years ago, Chanock et al. [1] described an artificial medium that enabled the identification of the aetiological agent of an atypical pneumonia first reported 20 years earlier, which was first described as pleuropneumonia-like organisms (PPLO) and renamed as Mycoplasma pneumoniae [2]. More recently, genome analysis has revealed the bacterium’s limited metabo- lism and biosynthesis of carbohydrates, proteins, nucleic acid and lipids, showing that the agent is well adapted to its only host, humans. We are, however, still unable to mimic the natural environment of M. pneu- moniae: faster growth in culture media is needed for diagnostic purposes. It takes more than 10 days — in fact often up to three weeks — to grow M. pneumo- niae from respiratory specimens taken from patients with an interstitial pneumonia. The organism can be cultured from samples taken in the acute phase of the infection, but because of the length of time needed, culture techniques have not been established in most bacteriological laboratories.
机译:大约50年前,Chanock等人。 [1]描述了一种人工培养基,该培养基能够鉴定20年前首次报道的非典型肺炎的病原体,该病原先被描述为类胸膜肺炎生物(PPLO),并更名为肺炎支原体[2]。最近,基因组分析揭示了细菌有限的代谢和碳水化合物,蛋白质,核酸和脂质的生物合成,表明该药物非常适合其唯一的宿主人类。但是,我们仍然无法模仿肺炎支原体的自然环境:为了诊断目的,需要培养基快速生长。从间质性肺炎患者的呼吸道标本中培养出肺炎支原体需要10天以上的时间,实际上通常要长达三周。可以从感染急性期采集的样本中培养出这种生物,但是由于所需时间长,大多数细菌实验室尚未建立培养技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号